Together with leading compounding pharmacists, MHR has released a capsule that combines oral components. One of these components is a medication that has gained attention for its efficacy in the treatment of genetic hair loss (androgenetic alopecia), which is commonly known as male or female pattern baldness. Like Finas(teride), it belongs to a class of drugs known as 5-alpha-reductase inhibitors, and it works by reducing the levels of dihydrotestosterone (DHT), the hormone linked to hair loss. This component is considered to be more potent in inhibiting DHT production compared to finas(teride), another 5-alpha-reductase inhibitor commonly used for hair loss because it blocks both type 1 and type 2 receptors (dual blockers). It has shown promising results in some studies, with the potential for hair regrowth and slowing down hair loss progression.
FR-8-For-Him-Extra-Strength (Follicular Regenerate)
One of the components in this medication has a dual blocking effect on inhibiting the creation of DHT, which attacks the hair follicle and contributes to hair loss. This tablet can only be used by men and should not be used by women or children.